Summary

Structural Heart Devices Market Summary

The global structural heart devices market size was estimated at USD 16.13 billion in 2024 and is projected to reach USD 50.99 billion by 2033, growing at a CAGR of 13.5% from 2025 to 2033. Rising valvular heart diseases drive the growth of the market.

According to an Oxford Academic article published in January 2025, the global age-standardized prevalence of cardiovascular disease stands at approximately 7,179 cases per 100,000 individuals, highlighting the substantial and persistent global burden of heart-related conditions. The rising prevalence of cardiovascular conditions highlights the need for timely interventions. Structural heart devices are key in managing valvular and congenital heart diseases. With a focus on early diagnosis and personalized care, technologies such as transcatheter valves and septal closure devices are improving outcomes and minimizing the need for invasive surgeries.

The rising prevalence of cardiovascular diseases (CVDs) in the U.S., including conditions such as arrhythmias and heart failure, is significantly driven by several key factors. A sedentary lifestyle has become increasingly common, with many individuals engaging in insufficient physical activity, which contributes to obesity and related health issues. According to the America Heart Association, in January 2024, the U.S. reported 931,578 deaths linked to cardiovascular disease, nearly 3,000 higher than the previous year, with the age-adjusted death rate climbing to 233.3 per 100,000 people, reflecting a 4.0% increase. These statistics underscore a growing need for advanced treatment options, such as transcatheter heart valves and left atrial appendage closure devices, to manage high-risk patients and reduce mortality linked to structural heart conditions.


Global Structural Heart Devices Market Report Segmentation

This report forecasts revenue growth and analyzes the latest trends in each sub-segments from 2021 to 2033 at the global, regional, and country levels. For this report, Grand View Research has segmented the global structural heart devices market report based on type and region:

• Type Outlook (Revenue USD Million, 2021 - 2033)
• TAVR (Transcatheter Aortic Valve Replacement)
• SAVR (Surgical Aortic Valve Replacement)
• Mitral Repair (Annuloplasty)
• LAAC (Left Atrial Appendage Closure)
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o China
o India
o Australia
o South Korea
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.3. Competitive Insights
Chapter 3. Global Structural Heart Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising cardiovascular incidence
3.2.1.2. Increasing initiatives by the government and research bodies
3.2.1.3. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High cost of treatments
3.2.2.2. Regulatory challenges and approval delays
3.3. Global Structural Heart Devices: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Technology Landscape
3.5. Case Study Analysis
Chapter 4. Global Structural Heart Devices Market Segment Analysis, By Type, 2021 - 2033 (USD Million)
4.1. Definition and Scope
4.2. Type Market Share Analysis, 2024 & 2033
4.3. Segment Dashboard
4.4. Global Structural Heart Devices Market, by Type, 2021 to 2033
4.5. TAVR (Transcatheter Aortic Valve Replacement)
4.5.1. TAVR (Transcatheter Aortic Valve Replacement) market estimates and forecasts, 2021 to 2033 (USD Million)
4.6. SAVR (Surgical Aortic Valve Replacement)
4.6.1. SAVR (Surgical Aortic Valve Replacement) market estimates and forecasts, 2021 to 2033 (USD Million)
4.7. Mitral Repair (Annuloplasty)
4.7.1. Mitral Repair (Annuloplasty) market estimates and forecasts, 2021 to 2033 (USD Million)
4.8. LAAC (Left Atrial Appendage Closure)
4.8.1. LAAC (Left Atrial Appendage Closure) market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. Structural Heart Devices Market Segment Analysis, By Region, 2021 - 2033 (USD Million)
5.1. Regional Market Share Analysis, 2024 & 2034
5.2. Regional Market Dashboard
5.3. Regional Market Snapshot
5.4. Structural Heart Devices Market Share by Region, 2024 & 2033:
5.5. North America
5.5.1. North America structural heart devices market, 2021 - 2033 (USD Million)
5.5.2. U.S.
5.5.2.1. Key Country Dynamics
5.5.2.2. Regulatory Scenario
5.5.2.3. Competitive Scenario
5.5.2.4. U.S. structural heart devices market, 2021 - 2033 (USD Million)
5.5.3. Canada
5.5.3.1. Key Country Dynamics
5.5.3.2. Regulatory Scenario
5.5.3.3. Competitive Scenario
5.5.3.4. Canada structural heart devices market, 2021 - 2033 (USD Million)
5.5.4. Mexico
5.5.4.1. Key Country Dynamics
5.5.4.2. Regulatory Scenario
5.5.4.3. Competitive Scenario
5.5.4.4. Mexico structural heart devices market, 2021 - 2033 (USD Million)
5.6. Europe
5.6.1. Europe structural heart devices market, 2021 - 2033 (USD Million)
5.6.2. UK
5.6.2.1. Key Country Dynamics
5.6.2.2. Regulatory Scenario
5.6.2.3. Competitive Scenario
5.6.2.4. UK structural heart devices market, 2021 - 2033 (USD Million)
5.6.3. Germany
5.6.3.1. Key Country Dynamics
5.6.3.2. Regulatory Scenario
5.6.3.3. Competitive Scenario
5.6.3.4. Germany structural heart devices market, 2021 - 2033 (USD Million)
5.6.4. France
5.6.4.1. Key Country Dynamics
5.6.4.2. Regulatory Scenario
5.6.4.3. Competitive Scenario
5.6.4.4. France structural heart devices market, 2021 - 2033 (USD Million)
5.6.5. Italy
5.6.5.1. Key Country Dynamics
5.6.5.2. Regulatory Scenario
5.6.5.3. Competitive Scenario
5.6.5.4. Italy structural heart devices market, 2021 - 2033 (USD Million)
5.6.6. Spain
5.6.6.1. Key Country Dynamics
5.6.6.2. Regulatory Scenario
5.6.6.3. Competitive Scenario
5.6.6.4. Spain structural heart devices market, 2021 - 2033 (USD Million)
5.6.7. Norway
5.6.7.1. Key Country Dynamics
5.6.7.2. Regulatory Scenario
5.6.7.3. Competitive Scenario
5.6.7.4. Norway structural heart devices market, 2021 - 2033 (USD Million)
5.6.8. Sweden
5.6.8.1. Key Country Dynamics
5.6.8.2. Regulatory Scenario
5.6.8.3. Competitive Scenario
5.6.8.4. Sweden structural heart devices market, 2021 - 2033 (USD Million)
5.6.9. Denmark
5.6.9.1. Key Country Dynamics
5.6.9.2. Regulatory Scenario
5.6.9.3. Competitive Scenario
5.6.9.4. Denmark structural heart devices market, 2021 - 2033 (USD Million)
5.7. Asia Pacific
5.7.1. Japan
5.7.1.1. Key Country Dynamics
5.7.1.2. Regulatory Scenario
5.7.1.3. Competitive Scenario
5.7.1.4. Japan structural heart devices market, 2021 - 2033 (USD Million)
5.7.2. China
5.7.2.1. Key Country Dynamics
5.7.2.2. Regulatory Scenario
5.7.2.3. Competitive Scenario
5.7.2.4. China structural heart devices market, 2021 - 2033 (USD Million)
5.7.3. India
5.7.3.1. Key Country Dynamics
5.7.3.2. Regulatory Scenario
5.7.3.3. Competitive Scenario
5.7.3.4. India structural heart devices market, 2021 - 2033 (USD Million)
5.7.4. Australia
5.7.4.1. Key Country Dynamics
5.7.4.2. Regulatory Scenario
5.7.4.3. Competitive Scenario
5.7.4.4. Australia structural heart devices market, 2021 - 2033 (USD Million)
5.7.5. South Korea
5.7.5.1. Key Country Dynamics
5.7.5.2. Regulatory Scenario
5.7.5.3. Competitive Scenario
5.7.5.4. South Korea structural heart devices market, 2021 - 2033 (USD Million)
5.7.6. Thailand
5.7.6.1. Key Country Dynamics
5.7.6.2. Regulatory Scenario
5.7.6.3. Competitive Scenario
5.7.6.4. Thailand structural heart devices market, 2021 - 2033 (USD Million)
5.8. Latin America
5.8.1. Brazil
5.8.1.1. Key Country Dynamics
5.8.1.2. Regulatory Scenario
5.8.1.3. Competitive Scenario
5.8.1.4. Brazil structural heart devices market, 2021 - 2033 (USD Million)
5.8.2. Argentina
5.8.2.1. Key Country Dynamics
5.8.2.2. Regulatory Scenario
5.8.2.3. Competitive Scenario
5.8.2.4. Argentina structural heart devices market, 2021 - 2033 (USD Million)
5.9. MEA
5.9.1. South Africa
5.9.1.1. Key Country Dynamics
5.9.1.2. Regulatory Scenario
5.9.1.3. Competitive Scenario
5.9.1.4. South Africa structural heart devices market, 2021 - 2033 (USD Million)
5.9.2. Saudi Arabia
5.9.2.1. Key Country Dynamics
5.9.2.2. Regulatory Scenario
5.9.2.3. Competitive Scenario
5.9.2.4. Saudi Arabia structural heart devices market, 2021 - 2033 (USD Million)
5.9.3. UAE
5.9.3.1. Key Country Dynamics
5.9.3.2. Regulatory Scenario
5.9.3.3. Competitive Scenario
5.9.3.4. UAE structural heart devices market, 2021 - 2033 (USD Million)
5.9.4. Kuwait
5.9.4.1. Key Country Dynamics
5.9.4.2. Regulatory Scenario
5.9.4.3. Competitive Scenario
5.9.4.4. Kuwait structural heart devices market, 2021 - 2033 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company Categorization
6.3. Company Profiles
6.3.1. Boston Scientific Corporation
6.3.1.1. Company overview
6.3.1.2. Financial performance
6.3.1.3. Type benchmarking
6.3.1.4. Strategic initiatives
6.3.2. Medtronic plc
6.3.2.1. Company overview
6.3.2.2. Financial performance
6.3.2.3. Type benchmarking
6.3.2.4. Strategic initiatives
6.3.3. Edwards Lifesciences Corporation
6.3.3.1. Company overview
6.3.3.2. Financial performance
6.3.3.3. Type benchmarking
6.3.3.4. Strategic initiatives
6.3.4. Abbott Laboratories
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Type benchmarking
6.3.4.4. Strategic initiatives
6.3.5. ST. JUDE MEDICAL
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Type benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Biomerics
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Type benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Comed BV
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Type benchmarking
6.3.7.4. Strategic initiatives
6.3.8. LivaNova PLC
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Type benchmarking
6.3.8.4. Strategic initiatives
6.3.9. JenaValve Technology, Inc.
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Type benchmarking
6.3.9.4. Strategic initiatives
6.3.10. CardioKinetix
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Type benchmarking
6.3.10.4. Strategic initiatives